These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8100693)

  • 1. Risk for developing tuberculosis among anergic patients infected with HIV.
    Moreno S; Baraia-Etxaburu J; Bouza E; Parras F; Pérez-Tascón M; Miralles P; Vicente T; Alberdi JC; Cosín J; López-Gay D
    Ann Intern Med; 1993 Aug; 119(3):194-8. PubMed ID: 8100693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
    Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
    Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).
    Anastos K; Kalish LA; Palacio H; Benson CA; Delapenha R; Chirgwin K; Stonis L; Telzak EE
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):141-7. PubMed ID: 10360806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the risk of tuberculosis among HIV-infected patients.
    Guelar A; Gatell JM; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró JM; Mallolas J; Zamora L; González J
    AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis.
    MMWR Recomm Rep; 1991 Apr; 40(RR-5):27-32. PubMed ID: 2034206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Wilcosky TC; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1997 Jan; 126(2):123-32. PubMed ID: 9005746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive medicine for HIV-infected patients: an analysis of isoniazid prophylaxis for tuberculin reactors and for anergic patients.
    Rose DN; Schechter CB; Sacks HS
    J Gen Intern Med; 1992; 7(6):589-94. PubMed ID: 1360493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE; Schein MF; Hall CA; Barnes SA
    Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection.
    Villarino ME; Geiter LJ; Schulte JM; Castro KG
    AIDS; 1994 Apr; 8(4):477-81. PubMed ID: 8011250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.
    Blatt SP; Hendrix CW; Butzin CA; Freeman TM; Ward WW; Hensley RE; Melcher GP; Donovan DJ; Boswell RN
    Ann Intern Med; 1993 Aug; 119(3):177-84. PubMed ID: 8100691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group.
    Klein RS; Sobel J; Flanigan T; Smith D; Margolick JB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):238-44. PubMed ID: 10077171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).
    Antonucci G; Girardi E; Raviglione MC; Ippolito G
    JAMA; 1995 Jul; 274(2):143-8. PubMed ID: 7596002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.